# FDA Inspection 909374 - Novo Nordisk A/S - 25a-B - October 10, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as-25a-b/fdfdb519-3bb2-4a70-9cb0-87607bf74333/
Source feed: FDA_Inspections

> FDA Inspection 909374 for Novo Nordisk A/S - 25a-B on October 10, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 909374
- Company Name: Novo Nordisk A/S - 25a-B
- Inspection Date: 2014-10-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1207487 - 2022-11-04](https://www.globalkeysolutions.net/api/records/fda_inspections/novo-nordisk-as-25a-b/ea79a155-481b-4679-9086-1db6a43fbf49/)
- [FDA Inspection 1118196 - 2018-06-14](https://www.globalkeysolutions.net/api/records/fda_inspections/novo-nordisk-as-25a-b/156a68b4-323b-4516-bbc3-f0d2f48afd63/)
- [FDA Inspection 957571 - 2016-01-22](https://www.globalkeysolutions.net/api/records/fda_inspections/novo-nordisk-as-25a-b/a97b3042-eb3e-405d-901c-868c1f2c0ae4/)
- [FDA Inspection 933969 - 2015-06-18](https://www.globalkeysolutions.net/api/records/fda_inspections/novo-nordisk-as-25a-b/3a79a91e-3659-4d5d-8ff3-895d6b9ca4b1/)
- [FDA Inspection 909374 - 2014-10-10](https://www.globalkeysolutions.net/api/records/fda_inspections/novo-nordisk-as-25a-b/30c777f4-2e80-4bb2-bdc8-20f7acb44537/)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-as-25a-b/017e6784-9871-4c62-9884-314e60ba61b7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
